Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125318081 | 12531808 | 1 | I | 20160628 | 20160706 | 20160706 | EXP | US-ABBVIE-16K-163-1664763-00 | ABBVIE | 0.00 | M | Y | 0.00000 | 20160706 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125318081 | 12531808 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 1057942 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
| 125318081 | 12531808 | 2 | SS | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | UNKNOWN | 0 | CAPSULE | |||||||||
| 125318081 | 12531808 | 3 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125318081 | 12531808 | 4 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125318081 | 12531808 | 5 | C | NOVOLOG | INSULIN ASPART | 1 | 0 | ||||||||||||
| 125318081 | 12531808 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125318081 | 12531808 | 7 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125318081 | 12531808 | 8 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
| 125318081 | 12531808 | 9 | C | LEVEMIR | INSULIN DETEMIR | 1 | 0 | ||||||||||||
| 125318081 | 12531808 | 10 | C | GEMFIBROZIL. | GEMFIBROZIL | 1 | 0 | ||||||||||||
| 125318081 | 12531808 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 125318081 | 12531808 | 12 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125318081 | 12531808 | 1 | Psoriasis |
| 125318081 | 12531808 | 2 | Pancreatitis chronic |
| 125318081 | 12531808 | 3 | Product used for unknown indication |
| 125318081 | 12531808 | 4 | Product used for unknown indication |
| 125318081 | 12531808 | 5 | Product used for unknown indication |
| 125318081 | 12531808 | 6 | Product used for unknown indication |
| 125318081 | 12531808 | 7 | Product used for unknown indication |
| 125318081 | 12531808 | 8 | Product used for unknown indication |
| 125318081 | 12531808 | 9 | Product used for unknown indication |
| 125318081 | 12531808 | 10 | Product used for unknown indication |
| 125318081 | 12531808 | 11 | Product used for unknown indication |
| 125318081 | 12531808 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125318081 | 12531808 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125318081 | 12531808 | Blood glucose increased | |
| 125318081 | 12531808 | Blood pressure increased | |
| 125318081 | 12531808 | Pancreatitis chronic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125318081 | 12531808 | 1 | 201512 | 0 |